17 hrs ago
NEWAMD: The reason Judi Dench can no longer read scripts
When Dame Judi Dench announced she was no longer able to read scripts because of an eye condition, some 500,000 people in Britain understood what she was going through.
Trending on the Topix Network
Sun Mar 09, 2014
Nutrition News: Leafy greens are nutrition rockstars
We could pick a lot of food to fit this category, but when it comes to nutrition, leafy greens are rockstars, according to the latest issue of Food & Nutrition magazine.
Green Bay Press-Gazette
Eyes, vision can affect your overall health
Your eyes are a very important part of your overall health and there are many things you can do to keep them healthy and seeing their best.
Halton smokers urged to quit to avoid contracting eye disease
YOUNG smokers in Halton face increased risks of cataracts, age-related macular degeneration and blindness in later life, a local optician has warned.
Sat Mar 08, 2014
New discovery about dog eyes [Life Lines]
Despite having a close relationship with dogs for thousands of years, we are still making new discoveries about our canine friends.
Fri Mar 07, 2014
Investor's Business Daily
Regeneron falls on FDA probe
Shares of the drugmaker, whose Eylea treatment for wet age-related macular degeneration is a top seller, plunged 10% Fri.
Dr. Ronald Frenkel of Stuart to present method at Association for...
Dr. Frenkel will present this at the Association for Research in Vision and Ophthalmology, the largest eye research meeting in the world.
Medical News Today
Sight-saving eye drops could replace injections
Drug treatments for diseases that cause blindness could be delivered by eye drops instead of uncomfortable and costly eye injections, say UK researchers.
Thu Mar 06, 2014
Prince George Citizen
Drug spending growth rate slows due to increased generics, government policies
A new report says Canadians spent nearly $30 billion on prescription medications in 2013 and another $5 billion on over-the-counter drugs.
Generics slow Canadian drug spending growth
The impact of the availability of lower-cost generic products helped to slow the growth of spending on prescription drugs, as did government policies over the past five years, the Canadian Institute for Health Information said.
Lincoln Daily News
Italian watchdog says Novartis, Roche colluded over eye drug
Italy's antitrust authorities said Swiss drugmakers Novartis and Roche colluded to try to stop cancer drug Avastin being used to treat a serious eye disease, and fined the companies 182.5 million euros .
Wed Mar 05, 2014
New innovation could mean eye injections are a thing of the past
Drugs used to treat blindness-causing disorders could be successfully administered by eye drops rather than unpleasant and expensive eye injections, according to new research led by UCL scientists that could be a breakthrough for the millions worldwide suffering from age-related macular degeneration and other eye disorders.
Stemcells, Inc. And Advanced Cell Technology: The Race To Treat AMD
In my last two articles; " Advanced Cell Technology: A Balanced Perspective Of Risk and Reward " and " StemCells, Inc., And Neuralstem, Inc.: A Side-By-Side Analysis ", I first took a broad, balanced view of the investment risk and return profile of Advanced Cell Technology based on recent developments, and in my second article, I took an even ... (more)
Novartis, Roche fined for collusion over Avastin
Italy's antitrust body said it has slapped Swiss pharma giants Novartis and Roche with fine totaling 182.5 million euros for allegedly manipulating sales of a cheap drug used to treat sight problems, including macular degeneration "The two groups made an illicit deal to prevent the use of a very cheap drug, Avastin, in treating the most widespread ... (more)
Tue Mar 04, 2014
The Motley Fool
Regeneron's Eylea: The Anatomy Of A Blockbuster Drug
Few drugs become multi-billion blockbusters, but those that do usually have similar characteristics.
Santen and TRACON Announce Agreement for the Development and...
Pre-clinical and clinical data from TRACON's ongoing development of TRC105 in combination with anti-VEGF products in oncology indicate inhibiting both the endoglin and VEGF pathways has the potential to show advantages over inhibiting VEGF alone in the treatment of conditions such as wet age-related macular degeneration .
Ophthotech to Host R&D Day on March 7, 2014
A panel featuring leading retinal specialists will discuss the company's expanded clinical programs for Fovistaa anti-PDGF therapy in combination with anti-VEGF drugs for wet AMD.
Global macular degeneration market: Latest market research analysed
This report provides information on the therapeutic development for Macular Degeneration, complete with latest updates, and special features on late-stage and discontinued projects.
Mon Mar 03, 2014
Customer Interaction Solutions
Acucela Completes Enrollment in the Emixustat Hydrochloride Phase 2b/3 Clinical Trial
Acucela Inc. , a clinical-stage biotechnology company that specializes in discovering and developing novel therapeutics to treat and slow the progression of sight-threatening ophthalmic diseases, today announced that it has completed enrollment in its ongoing Phase 2b/3 clinical trial investigating emixustat in subjects with geographic atrophy ... (more)